1. Kim H et al. Quantitative analysis of nasal transcripts reveals potential biomarkers for Parkinson''s disease. Sci Rep. 2019 Jul 319(1) (±³½Å)
2. Ham S et al. Cell-Based Screen Using Amyloid Mimic ¥â23 Expression Identifies Peucedanocoumarin III as a Novel Inhibitor of ¥á-Synuclein and Huntingtin Aggregates. Mol Cells. 2019 Jun 3042(6):480-494 (±³½Å)
3. Kim H et al. Rhododendrin-Induced RNF146 Expression via Estrogen Receptor ¥â Activation is Cytoprotective Against 6-OHDA-Induced Oxidative Stress. Int J Mol Sci. 2019 Apr 1020(7). (±³½Å)
4. Yun SP et al. ¥á-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism. Mol Neurodegener. 2018 Jan 813(1) (±³½Å)
5. Kim H et al. Estrogen receptor activation contributes to RNF146 expression and neuroprotection in Parkinson''s disease models. Oncotarget. 2017 Oct 118(63) (±³½Å)
6. Kang H et al. PARIS reprograms glucose metabolism by HIF-1¥á induction in dopaminergic neurodegeneration..Biochem Biophys Res Commun. 2018 Jan 22495(4) (±³½Å)
7. Kim H et al. CRISPR-Cas9 Mediated Telomere Removal Leads to Mitochondrial Stress and Protein Aggregation. Int J Mol Sci. 2017 Oct 318(10) (±³½Å)
8. Kang H et al. Activation of the ATF2/CREB-PGC-1¥á pathway by metformin leads to dopaminergic neuroprotection. Oncotarget. 2017 Jul 258(30):48603-48618.(±³½Å)
9. Yun SP et al. VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2. Cell Death Dis. 2017 Apr 68(4) (±³½Å)
10. Ham S et al. Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson''s disease model. Sci Rep. 2017 Apr 37(1) (±³½Å)
11. Lee Y et al. PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival. Cell Rep. 2017 Jan 2418(4):918-932 (1ÀúÀÚ)